cardiovascular-agents has been researched along with buflomedil* in 2 studies
1 trial(s) available for cardiovascular-agents and buflomedil
| Article | Year |
|---|---|
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
1 other study(ies) available for cardiovascular-agents and buflomedil
| Article | Year |
|---|---|
Cardiorespiratory and metabolic effects of buflomedil: case reports.
An extensive study has been performed of the cardiovascular, respiratory and metabolic effects of buflomedil. The results indicate that the drug, at the administered dose, does not alter the patient physiological stability. An improved perfusion regimen in peripheral tissues and an optimization of cardiac energetics are also directly or indirectly implied in the results. Topics: Aged; Arteriosclerosis; Biological Transport, Active; Blood Pressure; Cardiovascular Agents; Diabetic Angiopathies; Hemodynamics; Humans; Male; Middle Aged; Oxygen; Oxygen Consumption; Pyrrolidines; Vascular Resistance | 1986 |